Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionTwo Sigma Advisers, Lp
Latest Disclosed Ownership98,360 shares
Latest Disclosed Value $ 44,592,490
Two Sigma Advisers, Lp ownership in VRTX / Vertex Pharmaceuticals Incorporated

On February 17, 2026 - Two Sigma Advisers, Lp filed a 13F-HR form disclosing ownership of 98,360 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $44,592,490 USD as of December 31, 2025. The entity filed a previous 13F-HR on November 14, 2025 disclosing 11,500 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 755.30% during the quarter. The current value of the position is $43,950,199 USD.

Two Sigma Advisers, Lp has a history of taking positions in derivatives of the underlying security (VRTX) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

VRTX / Vertex Pharmaceuticals Incorporated Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-02-17 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 98,360 86,860 755.30 44,592 890.27 0.0867
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 11,500 10,600 1,177.78 4,504 1,025.75 0.0090
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 900 900 401 0.0008
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -3,200 -100.00 0 -100.00
2025-02-14 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,200 -26,200 -89.12 1,289 -90.58 0.0030
2024-11-14 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 29,400 -142,400 -82.89 13,673 -83.02 0.0320
2024-08-14 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 171,800 49,800 40.82 80,526 57.90 0.1796
2024-05-15 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 122,000 34,500 39.43 50,997 43.24 0.1181
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 87,500 -55,900 -38.98 35,603 -28.60 0.0834
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 143,400 -71,000 -33.12 49,866 -33.91 0.1277
2023-08-14 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 214,400 154,000 254.97 75,450 296.47 0.1922
2023-05-15 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 60,400 42,600 239.33 19,030 270.23 0.0491
2023-02-14 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,800 -5,200 -22.61 5,140 -22.81 0.0144
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 23,000 -1,700 -6.88 6,659 -4.32 0.0193
2022-08-15 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 24,700 6,900 38.76 6,960 49.84 0.0197
2022-05-16 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17,800 5,500 44.72 4,645 71.97 0.0123
2022-02-14 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 12,300 -770,400 -98.43 2,701 -98.10 0.0068
2021-11-15 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 782,700 781,700 78,170.00 141,974 70,184.16 0.3680
2021-08-16 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,000 1,000 202 0.0005
2021-05-17 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -262,837 -100.00 0 -100.00
2021-02-16 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 262,837 -514,800 -66.20 62,119 -70.64 0.1660
2020-11-16 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 777,637 -438,275 -36.04 211,611 -40.05 0.6045
2020-09-15 2020-06-30 13F/A-1 VERTEX PHARMACEUTICALS COM 92532F100 1,215,912 113,900 10.34 352,991 34.61 1.0371
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,215,912 113,900 352,991 1,020,026.7566
2020-05-15 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,102,012 -102,700 -8.52 262,224 -0.59 1.0035
2020-02-14 2019-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,204,712 301,100 33.32 263,772 72.30 0.6120
2019-11-14 2019-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 903,612 -32,100 -3.43 153,090 -10.78 0.3747
2019-08-14 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 935,712 -67,700 -6.75 171,591 -7.04 0.4270
2019-05-15 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,003,412 258,400 34.68 184,578 49.51 0.4654
2019-02-14 2018-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 745,012 219,000 41.63 123,456 21.77 0.3372
2018-11-14 2018-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 526,012 192,600 57.77 101,384 78.91 0.2474
2018-08-14 2018-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 333,412 -479,800 -59.00 56,667 -57.24 0.1524
2018-05-15 2018-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 813,212 -414,200 -33.75 132,537 -27.95 0.3594
2018-02-14 2017-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,227,412 368,162 42.85 183,940 40.80 0.4959
2017-11-14 2017-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 859,250 -3,351 -0.39 130,640 17.52 0.3703
2017-08-14 2017-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 862,601 -295,767 -25.53 111,163 -12.24 0.3669
2017-05-15 2017-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,158,368 63,539 5.80 126,668 57.05 0.4153
2017-02-14 2016-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,094,829 834,476 320.52 80,656 255.23 0.3085
2016-11-14 2016-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 260,353 28,067 12.08 22,705 13.63 0.0967
2016-08-15 2016-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 232,286 -713,380 -75.44 19,981 -73.42 0.1015
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 945,666 672,976 246.79 75,171 119.07 0.4206
2016-02-16 2015-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 272,690 -28,606 -9.49 34,313 7.06 0.2045
2015-11-16 2015-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 301,296 287,800 2,132.48 32,050 1,823.77 0.2021
2016-02-09 2015-06-30 13F/A-1 VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 13,496 13,496 1,666 0.0128
2015-08-14 2015-06-30 13F VERTEX PHARMACEUTICALS COMMON STOCK 92532F100 13,396 1,655 0.0129
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2016-05-16 2016-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 0 n/a n/a n/a
2015-05-15 2015-03-31 13F VERTEX PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2016-02-09 2014-12-31 13F/A VERTEX PHARMACEUTICALS COM Call 3,000 356 n/a n/a n/a
2015-02-17 2014-12-31 13F VERTEX PHARMACEUTICALS COM Call 3,000 356 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.